Enveda Secures $130 Million to Deliver Multiple Clinical Readouts Colorado-based biotechnology company leveraging AI to develop new medicines from naturally available materials, Enveda Biosciences, has raised $130 million in Series C funding round spearheaded by FVP and Kinnevik. New and existing investors, including Premji Invest - US, Baillie Gifford, Lingotto Innovation, Dimension Capital, Lux Capital, True Ventures, The Nature Conservancy, Henry R. Kravis, and Cresset Partners, supported the investment round, which boosted the company’s total funding to $360 million. Read more: https://nextdigitalhealth.com/funding-news/enveda-secures-130-million-to-deliver-multiple-clinical-readouts/ #HealthcareNews #HealthcareInnovation #HealthcareTechnology #Ai #medicaldevice